Trial
NCT01118728
Extension Study for Long Term Evaluation of SAR153191 (REGN88) in Patients With Ankylosing Spondylitis
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Sanofi
Collaborators
Regeneron Pharmaceuticals
Condition
Ankylosing Spondylitis
Intervention
Sarilumab
Why stopped
Lack of benefit on efficacy
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-06-21